CCND1 and neoplasm: A previous study reveals that berberine suppresses the activity of the AP-1 signaling pathway and decreases the binding of transcription factors to the Cyclin D1 AP-1 motif, indicating that transcriptional inhibition of Cyclin D1 may be involved in the anti-tumor effect of berberine [11].